查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1803052

全球人工智慧驅動的慢性疼痛管理市場預測（至 2032 年）：按組件、部署類型、分銷管道、應用、最終用戶和地區進行分析

AI Chronic Pain Management Market Forecasts to 2032 - Global Analysis By Component (Software, Hardware, and Services), Deployment Mode, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球 AI 慢性疼痛管理市場預計在 2025 年達到 60.7 億美元，到 2032 年將達到 207.8 億美元，預測期內的複合年成長率為 19.2%。

AI慢性疼痛管理是指應用人工智慧技術來評估、監測和治療長期疼痛狀況。它整合了機器學習、預測分析和數位工具，以個人化疼痛管理策略，提高診斷準確性並最佳化治療效果。透過分析患者數據、穿戴式裝置輸入和病歷，AI可以實現早期療育，減少鴉片類藥物依賴，並改善慢性疼痛患者的整體生活品質。

慢性疼痛的流行

全球慢性疼痛的增加推動了對創新疼痛管理解決方案的需求。由於人口老化和生活方式因素，關節炎、纖維肌痛和神經病變疼痛等疾病正變得越來越普遍。傳統的疼痛管理方法往往無法提供長期緩解，這激發了人們對人工智慧方法的興趣。人工智慧技術能夠更精確地分析患者數據並最佳化治療方案。隨著醫療保健系統尋求更有效、更具可擴展性的解決方案，人工智慧正逐漸成為個人化疼痛照護的關鍵推動因素。這種日益成長的需求正在推動醫院、診所和數位健康平台的投資和應用。

來自醫療保健專業人士的抵制

對數據可靠性、臨床檢驗以及缺乏人工監督的擔憂阻礙了人工智慧的推廣應用。醫生可能不願意相信演算法推薦，而更傾向於相信自己的臨床判斷，尤其是在複雜的疼痛病例中。有限的培訓和人工智慧工具的機會進一步加劇了醫學界的阻力。此外，監管的不確定性和倫理方面的考慮也導致人們對採用基於人工智慧的干涉措施猶豫不決。這種阻力減緩了市場滲透，並限制了人工智慧在疼痛治療領域中變革的潛力。

個人化預測護理

預測演算法可以透過預測疼痛發作並建議預防性干預措施來改善患者的治療效果。這些功能支持主動護理模式，減少對被動且通常無效的治療的依賴。與穿戴式裝置和行動應用程式的整合增強了即時監控和回饋迴路。隨著精準醫療的日益普及，人工智慧驅動的疼痛管理與個人化醫療的整體醫療趨勢相契合。這一機遇正吸引新興企業、科技巨頭和差異化醫療服務提供者。

預測不準確和病人受傷的風險

疼痛管理中的人工智慧系統容易受到資料集偏差或不完整導致的誤差的影響。誤診和不恰當的治療建議可能會對患者造成傷害，並削弱人們對該技術的信任。過度依賴缺乏適當臨床監督的演算法可能會加劇風險，尤其是在複雜或非典型病例中。預測模型中的錯誤可能導致治療延誤並使患者病情惡化。監管審查正在加強，以確保人工智慧應用的安全性和課責。這些風險對市場信譽和長期應用構成了重大威脅。

COVID-19的影響

新冠疫情加速了數位醫療工具（包括基於人工智慧的疼痛管理平台）的普及。封鎖措施和麵對面診療服務受限，增加了對遠端監控和虛擬諮詢的需求。人工智慧工具透過實現症狀追蹤和居家治療協調，填補了慢性疼痛護理領域的空白。然而，供應鏈中斷和資本重新配置暫時減緩了新型人工智慧解決方案的開發和部署。這種轉變將繼續支持人工智慧主導的慢性疼痛管理解決方案的成長。

預計軟體領域將成為預測期內最大的領域

由於個人化治療工具、用於疼痛預測的先進機器學習以及雲端遠距遠端醫療解決方案的日益普及，預計軟體領域將在預測期內佔據最大的市場佔有率。值得關注的趨勢包括基於應用程式的疼痛監測、與穿戴式裝置的整合以及基於訂閱的人工智慧平台。近期的進展體現在科技公司與醫療保健提供者之間的合作，旨在建立可互通的系統，以支援與電子健康記錄的一致性、簡化臨床決策流程以及以患者為中心、以結果主導的護理模式。

預計居家醫療領域在預測期內將以最高複合年成長率成長

預計居家醫療領域將在預測期內實現最高成長率，這得益於人們對物聯網設備、穿戴式感測器和基於人工智慧的監控系統等技術支援的遠端個人化護理的興趣日益濃厚。主要趨勢包括虛擬疼痛管理、即時數據驅動的自適應護理以及用於早期症狀檢測的預測工具。近期的創新促使技術提供者和醫療保健機構建立策略合作夥伴關係，提供擴充性的雲端支援平台，以增強患者能力，減少對醫院的依賴，並與不斷發展的報銷和基於價值的護理模式保持一致。

佔比最大的地區：

由於慢性疼痛患者數量的增加、數位醫療系統的擴展以及向非鴉片類藥物治療的轉變，預計亞太地區將在預測期內佔據最大的市場佔有率。人工智慧整合行動平台、穿戴式健康追蹤器和雲端基礎的分析等技術正日益普及。主要趨勢包括虛擬疼痛支援、多語言人工智慧工具和遠端醫療整合。近期發展包括區域高科技醫療夥伴關係、政府主導的數位醫療項目，以及對可擴展人工智慧解決方案的投資增加，以滿足多樣化的患者需求。

複合年成長率最高的地區：

由於慢性疼痛患者人數眾多、醫療保健體系健全以及數位化治療解決方案的廣泛應用，北美預計將在預測期內呈現最高的複合年成長率。人工智慧診斷工具、穿戴式疼痛監測設備以及與電子健康記錄相連的雲端整合平台等技術是關鍵推動因素。新興趨勢包括個人化疼痛管理演算法、神經調節洞察和虛擬指導。近期的里程碑包括醫院採用人工智慧工具的激增、生技藥品研究資金的增加以及基於遠端醫療的疼痛護理服務的擴展。

提供免費客製化：

此報告的訂閱者可以使用以下免費自訂選項之一：

  • 公司簡介
    • 對最多三家其他市場公司進行全面分析
    • 主要企業的SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究資訊來源
    • 初級研究資訊來源
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球人工智慧慢性疼痛管理市場（按組成部分）

  • 軟體
  • 硬體
  • 服務

6. 全球人工智慧慢性疼痛管理市場（按部署類型）

  • 雲端基礎
  • 本地

7. 全球人工智慧慢性疼痛管理市場（按分銷管道）

  • 線上平台
  • 離線

8. 全球人工智慧慢性疼痛管理市場（按應用）

  • 神經病變疼痛
  • 肌肉骨骼疼痛
  • 癌症相關疼痛
  • 偏頭痛和臉部疼痛
  • 纖維肌痛
  • 其他用途

9. 全球人工智慧慢性疼痛管理市場（按最終用戶）

  • 醫院和診所
  • 居家醫療
  • 門診手術中心
  • 研究所
  • 學術中心
  • 護理設施
  • 其他最終用戶

10. 全球人工智慧慢性疼痛管理市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章：企業概況

  • Johnson & Johnson
  • Horizon Therapeutics
  • Pfizer
  • Amgen
  • Medtronic
  • Mallinckrodt
  • Teva Pharmaceuticals
  • AstraZeneca
  • AbbVie
  • Bristol-Myers Squibb
  • Eli Lilly
  • Regeneron Pharmaceuticals
  • Boehringer Ingelheim
  • Novartis
  • GlaxoSmithKline（GSK）
Product Code: SMRC30577

According to Stratistics MRC, the Global AI Chronic Pain Management Market is accounted for $6.07 billion in 2025 and is expected to reach $20.78 billion by 2032 growing at a CAGR of 19.2% during the forecast period. AI Chronic Pain Management refers to the application of artificial intelligence technologies to assess, monitor, and treat long-term pain conditions. It integrates machine learning, predictive analytics, and digital tools to personalize pain management strategies, improve diagnosis accuracy, and optimize treatment outcomes. By analyzing patient data, wearable device inputs, and medical histories, AI enables early intervention, reduces dependency on opioids, and enhances overall quality of life for individuals suffering from chronic pain.

Market Dynamics:

Driver:

Growing prevalence of chronic pain

The increasing global burden of chronic pain is driving demand for innovative management solutions. Conditions such as arthritis, fibromyalgia, and neuropathic pain are becoming more prevalent due to aging populations and lifestyle factors. Traditional pain management methods often fall short in providing long-term relief, prompting interest in AI-driven approaches. AI technologies offer the potential to analyse patient data and optimize treatment plans with greater precision. As healthcare systems seek more effective and scalable solutions, AI is emerging as a key enabler of personalized pain care. This growing need is catalysing investments and adoption across hospitals, clinics, and digital health platforms.

Restraint:

Resistance from healthcare professionals

Concerns around data reliability, clinical validation, and loss of human oversight hinder adoption. Physicians may be reluctant to trust algorithmic recommendations over their clinical judgment, especially in complex pain cases. Limited training and exposure to AI tools further exacerbate resistance within the medical community. Additionally, regulatory ambiguity and ethical considerations contribute to hesitation in deploying AI-based interventions. This resistance slows market penetration and limits the full potential of AI in transforming pain care.

Opportunity:

Personalized and predictive treatment

Predictive algorithms can forecast pain flare-ups and recommend pre-emptive interventions, improving patient outcomes. These capabilities support proactive care models, reducing reliance on reactive and often ineffective treatments. Integration with wearable devices and mobile apps enhances real-time monitoring and feedback loops. As precision medicine gains traction, AI-driven pain management aligns with broader healthcare trends toward individualized care. This opportunity is attracting start-ups, tech giants, and healthcare providers seeking to differentiate their offerings.

Threat:

Risk of inaccurate predictions and patient harm

AI systems in pain management are vulnerable to inaccuracies stemming from biased or incomplete datasets. Misdiagnosis or inappropriate treatment recommendations can lead to patient harm, undermining trust in the technology. Overreliance on algorithms without adequate clinical oversight may exacerbate risks, especially in complex or atypical cases. Errors in prediction models can result in delayed care, worsening patient conditions. Regulatory scrutiny is intensifying to ensure safety and accountability in AI applications. These risks pose a significant threat to market credibility and long-term adoption.

Covid-19 Impact

The COVID-19 pandemic accelerated the adoption of digital health tools, including AI-based pain management platforms. Lockdowns and limited access to in-person care drove demand for remote monitoring and virtual consultations. AI tools helped bridge gaps in chronic pain care by enabling symptom tracking and treatment adjustments from home. However, supply chain disruptions and funding reallocations temporarily slowed development and deployment of new AI solutions. This shift continues to support growth in AI-driven chronic pain management solutions.

The softwaresegment is expected to be the largest during the forecast period

The softwaresegment is expected to account for the largest market share during the forecast period, fuelled by increasing adoption of personalized treatment tools, advanced machine learning for pain prediction, and cloud-enabled remote care solutions. Notable trends include app-based pain monitoring, integration with wearable devices, and subscription-based AI platforms. Recent advancements feature collaborations between tech companies and healthcare providers to create interoperable systems that align with electronic health records, streamline clinical decision-making, and support patient-centric, outcome-driven care models.

The homecaresegment is expected to have the highest CAGR during the forecast period

Over the forecast period, the homecaresegment is predicted to witness the highest growth rate, driven by growing interest in remote, individualized care supported by technologies like IoT-enabled devices, wearable sensors, and AI-based monitoring systems. Key trends include virtual pain management, real-time data-driven adaptive care, and predictive tools for early symptom detection. Recent innovations involve strategic alliances between technology providers and healthcare organizations to deliver scalable, cloud-supported platforms that empower patients, lower hospital dependency, and align with evolving reimbursement and value-based care models.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market sharedue to increasing cases of chronic pain, expanding digital healthcare systems, and a shift toward non-opioid treatment options. Technologies such as AI-integrated mobile platforms, wearable health trackers, and cloud-based analytics are gaining traction. Key trends include virtual pain support, multilingual AI tools, and telemedicine integration. Recent progress includes regional tech-healthcare partnerships, government-led digital health programs, and rising investments in scalable AI solutions tailored to diverse patient needs.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to widespread chronic pain cases, robust healthcare systems, and strong uptake of digital treatment solutions. Technologies such as AI-driven diagnostic tools, wearable pain monitoring devices, and cloud-integrated platforms linked to electronic health records are key enablers. Emerging trends include personalized pain management algorithms, neuromodulation insights, and virtual coaching. Recent milestones include a surge in hospital adoption of AI tools, increased funding for biologics research, and expanded telehealth-based pain care services.

Key players in the market

Some of the key players profiled in the AI Chronic Pain Management Market includeJohnson & Johnson, Horizon Therapeutics, Pfizer, Amgen, Medtronic, Mallinckrodt, Teva Pharmaceuticals, AstraZeneca, AbbVie, Bristol-Myers Squibb, Eli Lilly, Regeneron Pharmaceuticals, BoehringerIngelheim, Novartis, and GlaxoSmithKline (GSK).

Key Developments:

In July2025, Johnson & Johnson announced the launch of the VIRTUGUIDE(TM) System. This AI-powered, patient-matched solution is designed to support Lapidus procedures2, a type of bunion surgery that helps realign the foot by joining two bones near the arch (the first metatarsal bone and the medial cuneiform).3 The system uses pre-operative planning software, developed in collaboration with PeekMed(R), to assess each patient's bunion and make personalized recommendations for the intended correction.

In October2023,Amgen announced that it has completed its acquisition of Horizon Therapeutics plc for $116.50 per share in cash, representing a transaction equity value of approximately $27.8 billion.

Components Covered:

  • Software
  • Hardware
  • Services

Deployment Modes Covered:

  • Cloud-Based
  • On-Premises

Distribution Channels Covered:

  • Online Platforms
  • Offline

Applications Covered:

  • Neuropathic Pain
  • Musculoskeletal Pain
  • Cancer-related Pain
  • Migraine and Facial Pain
  • Fibromyalgia
  • Other Applications

End Users Covered:

  • Hospitals and Clinics
  • Homecare
  • Ambulatory Surgical Centers
  • Research Institutions
  • Academic Centers
  • Nursing Homes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global AI Chronic Pain Management Market, By Component

  • 5.1 Introduction
  • 5.2 Software
  • 5.3 Hardware
  • 5.4 Services

6 Global AI Chronic Pain Management Market, By Deployment Mode

  • 6.1 Introduction
  • 6.2 Cloud-Based
  • 6.3 On-Premises

7 Global AI Chronic Pain Management Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Online Platforms
  • 7.3 Offline

8 Global AI Chronic Pain Management Market, By Application

  • 8.1 Introduction
  • 8.2 Neuropathic Pain
  • 8.3 Musculoskeletal Pain
  • 8.4 Cancer-related Pain
  • 8.5 Migraine and Facial Pain
  • 8.6 Fibromyalgia
  • 8.7 Other Applications

9 Global AI Chronic Pain Management Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals and Clinics
  • 9.3 Homecare
  • 9.4 Ambulatory Surgical Centers
  • 9.5 Research Institutions
  • 9.6 Academic Centers
  • 9.7 Nursing Homes
  • 9.8 Other End Users

10 Global AI Chronic Pain Management Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Johnson & Johnson
  • 12.2 Horizon Therapeutics
  • 12.3 Pfizer
  • 12.4 Amgen
  • 12.5 Medtronic
  • 12.6 Mallinckrodt
  • 12.7 Teva Pharmaceuticals
  • 12.8 AstraZeneca
  • 12.9 AbbVie
  • 12.10 Bristol-Myers Squibb
  • 12.11 Eli Lilly
  • 12.12 Regeneron Pharmaceuticals
  • 12.13 Boehringer Ingelheim
  • 12.14 Novartis
  • 12.15 GlaxoSmithKline (GSK)

List of Tables

  • Table 1 Global AI Chronic Pain Management Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global AI Chronic Pain Management Market Outlook, By Component (2024-2032) ($MN)
  • Table 3 Global AI Chronic Pain Management Market Outlook, By Software (2024-2032) ($MN)
  • Table 4 Global AI Chronic Pain Management Market Outlook, By Hardware (2024-2032) ($MN)
  • Table 5 Global AI Chronic Pain Management Market Outlook, By Services (2024-2032) ($MN)
  • Table 6 Global AI Chronic Pain Management Market Outlook, By Deployment Mode (2024-2032) ($MN)
  • Table 7 Global AI Chronic Pain Management Market Outlook, By Cloud-Based (2024-2032) ($MN)
  • Table 8 Global AI Chronic Pain Management Market Outlook, By On-Premises (2024-2032) ($MN)
  • Table 9 Global AI Chronic Pain Management Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 10 Global AI Chronic Pain Management Market Outlook, By Online Platforms (2024-2032) ($MN)
  • Table 11 Global AI Chronic Pain Management Market Outlook, By Offline (2024-2032) ($MN)
  • Table 12 Global AI Chronic Pain Management Market Outlook, By Application (2024-2032) ($MN)
  • Table 13 Global AI Chronic Pain Management Market Outlook, By Neuropathic Pain (2024-2032) ($MN)
  • Table 14 Global AI Chronic Pain Management Market Outlook, By Musculoskeletal Pain (2024-2032) ($MN)
  • Table 15 Global AI Chronic Pain Management Market Outlook, By Cancer-related Pain (2024-2032) ($MN)
  • Table 16 Global AI Chronic Pain Management Market Outlook, By Migraine and Facial Pain (2024-2032) ($MN)
  • Table 17 Global AI Chronic Pain Management Market Outlook, By Fibromyalgia (2024-2032) ($MN)
  • Table 18 Global AI Chronic Pain Management Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 19 Global AI Chronic Pain Management Market Outlook, By End User (2024-2032) ($MN)
  • Table 20 Global AI Chronic Pain Management Market Outlook, By Hospitals and Clinics (2024-2032) ($MN)
  • Table 21 Global AI Chronic Pain Management Market Outlook, By Homecare (2024-2032) ($MN)
  • Table 22 Global AI Chronic Pain Management Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 23 Global AI Chronic Pain Management Market Outlook, By Research Institutions (2024-2032) ($MN)
  • Table 24 Global AI Chronic Pain Management Market Outlook, By Academic Centers (2024-2032) ($MN)
  • Table 25 Global AI Chronic Pain Management Market Outlook, By Nursing Homes (2024-2032) ($MN)
  • Table 26 Global AI Chronic Pain Management Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 27 North America AI Chronic Pain Management Market Outlook, By Country (2024-2032) ($MN)
  • Table 28 North America AI Chronic Pain Management Market Outlook, By Component (2024-2032) ($MN)
  • Table 29 North America AI Chronic Pain Management Market Outlook, By Software (2024-2032) ($MN)
  • Table 30 North America AI Chronic Pain Management Market Outlook, By Hardware (2024-2032) ($MN)
  • Table 31 North America AI Chronic Pain Management Market Outlook, By Services (2024-2032) ($MN)
  • Table 32 North America AI Chronic Pain Management Market Outlook, By Deployment Mode (2024-2032) ($MN)
  • Table 33 North America AI Chronic Pain Management Market Outlook, By Cloud-Based (2024-2032) ($MN)
  • Table 34 North America AI Chronic Pain Management Market Outlook, By On-Premises (2024-2032) ($MN)
  • Table 35 North America AI Chronic Pain Management Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 36 North America AI Chronic Pain Management Market Outlook, By Online Platforms (2024-2032) ($MN)
  • Table 37 North America AI Chronic Pain Management Market Outlook, By Offline (2024-2032) ($MN)
  • Table 38 North America AI Chronic Pain Management Market Outlook, By Application (2024-2032) ($MN)
  • Table 39 North America AI Chronic Pain Management Market Outlook, By Neuropathic Pain (2024-2032) ($MN)
  • Table 40 North America AI Chronic Pain Management Market Outlook, By Musculoskeletal Pain (2024-2032) ($MN)
  • Table 41 North America AI Chronic Pain Management Market Outlook, By Cancer-related Pain (2024-2032) ($MN)
  • Table 42 North America AI Chronic Pain Management Market Outlook, By Migraine and Facial Pain (2024-2032) ($MN)
  • Table 43 North America AI Chronic Pain Management Market Outlook, By Fibromyalgia (2024-2032) ($MN)
  • Table 44 North America AI Chronic Pain Management Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 45 North America AI Chronic Pain Management Market Outlook, By End User (2024-2032) ($MN)
  • Table 46 North America AI Chronic Pain Management Market Outlook, By Hospitals and Clinics (2024-2032) ($MN)
  • Table 47 North America AI Chronic Pain Management Market Outlook, By Homecare (2024-2032) ($MN)
  • Table 48 North America AI Chronic Pain Management Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 49 North America AI Chronic Pain Management Market Outlook, By Research Institutions (2024-2032) ($MN)
  • Table 50 North America AI Chronic Pain Management Market Outlook, By Academic Centers (2024-2032) ($MN)
  • Table 51 North America AI Chronic Pain Management Market Outlook, By Nursing Homes (2024-2032) ($MN)
  • Table 52 North America AI Chronic Pain Management Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 53 Europe AI Chronic Pain Management Market Outlook, By Country (2024-2032) ($MN)
  • Table 54 Europe AI Chronic Pain Management Market Outlook, By Component (2024-2032) ($MN)
  • Table 55 Europe AI Chronic Pain Management Market Outlook, By Software (2024-2032) ($MN)
  • Table 56 Europe AI Chronic Pain Management Market Outlook, By Hardware (2024-2032) ($MN)
  • Table 57 Europe AI Chronic Pain Management Market Outlook, By Services (2024-2032) ($MN)
  • Table 58 Europe AI Chronic Pain Management Market Outlook, By Deployment Mode (2024-2032) ($MN)
  • Table 59 Europe AI Chronic Pain Management Market Outlook, By Cloud-Based (2024-2032) ($MN)
  • Table 60 Europe AI Chronic Pain Management Market Outlook, By On-Premises (2024-2032) ($MN)
  • Table 61 Europe AI Chronic Pain Management Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 62 Europe AI Chronic Pain Management Market Outlook, By Online Platforms (2024-2032) ($MN)
  • Table 63 Europe AI Chronic Pain Management Market Outlook, By Offline (2024-2032) ($MN)
  • Table 64 Europe AI Chronic Pain Management Market Outlook, By Application (2024-2032) ($MN)
  • Table 65 Europe AI Chronic Pain Management Market Outlook, By Neuropathic Pain (2024-2032) ($MN)
  • Table 66 Europe AI Chronic Pain Management Market Outlook, By Musculoskeletal Pain (2024-2032) ($MN)
  • Table 67 Europe AI Chronic Pain Management Market Outlook, By Cancer-related Pain (2024-2032) ($MN)
  • Table 68 Europe AI Chronic Pain Management Market Outlook, By Migraine and Facial Pain (2024-2032) ($MN)
  • Table 69 Europe AI Chronic Pain Management Market Outlook, By Fibromyalgia (2024-2032) ($MN)
  • Table 70 Europe AI Chronic Pain Management Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 71 Europe AI Chronic Pain Management Market Outlook, By End User (2024-2032) ($MN)
  • Table 72 Europe AI Chronic Pain Management Market Outlook, By Hospitals and Clinics (2024-2032) ($MN)
  • Table 73 Europe AI Chronic Pain Management Market Outlook, By Homecare (2024-2032) ($MN)
  • Table 74 Europe AI Chronic Pain Management Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 75 Europe AI Chronic Pain Management Market Outlook, By Research Institutions (2024-2032) ($MN)
  • Table 76 Europe AI Chronic Pain Management Market Outlook, By Academic Centers (2024-2032) ($MN)
  • Table 77 Europe AI Chronic Pain Management Market Outlook, By Nursing Homes (2024-2032) ($MN)
  • Table 78 Europe AI Chronic Pain Management Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 79 Asia Pacific AI Chronic Pain Management Market Outlook, By Country (2024-2032) ($MN)
  • Table 80 Asia Pacific AI Chronic Pain Management Market Outlook, By Component (2024-2032) ($MN)
  • Table 81 Asia Pacific AI Chronic Pain Management Market Outlook, By Software (2024-2032) ($MN)
  • Table 82 Asia Pacific AI Chronic Pain Management Market Outlook, By Hardware (2024-2032) ($MN)
  • Table 83 Asia Pacific AI Chronic Pain Management Market Outlook, By Services (2024-2032) ($MN)
  • Table 84 Asia Pacific AI Chronic Pain Management Market Outlook, By Deployment Mode (2024-2032) ($MN)
  • Table 85 Asia Pacific AI Chronic Pain Management Market Outlook, By Cloud-Based (2024-2032) ($MN)
  • Table 86 Asia Pacific AI Chronic Pain Management Market Outlook, By On-Premises (2024-2032) ($MN)
  • Table 87 Asia Pacific AI Chronic Pain Management Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 88 Asia Pacific AI Chronic Pain Management Market Outlook, By Online Platforms (2024-2032) ($MN)
  • Table 89 Asia Pacific AI Chronic Pain Management Market Outlook, By Offline (2024-2032) ($MN)
  • Table 90 Asia Pacific AI Chronic Pain Management Market Outlook, By Application (2024-2032) ($MN)
  • Table 91 Asia Pacific AI Chronic Pain Management Market Outlook, By Neuropathic Pain (2024-2032) ($MN)
  • Table 92 Asia Pacific AI Chronic Pain Management Market Outlook, By Musculoskeletal Pain (2024-2032) ($MN)
  • Table 93 Asia Pacific AI Chronic Pain Management Market Outlook, By Cancer-related Pain (2024-2032) ($MN)
  • Table 94 Asia Pacific AI Chronic Pain Management Market Outlook, By Migraine and Facial Pain (2024-2032) ($MN)
  • Table 95 Asia Pacific AI Chronic Pain Management Market Outlook, By Fibromyalgia (2024-2032) ($MN)
  • Table 96 Asia Pacific AI Chronic Pain Management Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 97 Asia Pacific AI Chronic Pain Management Market Outlook, By End User (2024-2032) ($MN)
  • Table 98 Asia Pacific AI Chronic Pain Management Market Outlook, By Hospitals and Clinics (2024-2032) ($MN)
  • Table 99 Asia Pacific AI Chronic Pain Management Market Outlook, By Homecare (2024-2032) ($MN)
  • Table 100 Asia Pacific AI Chronic Pain Management Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 101 Asia Pacific AI Chronic Pain Management Market Outlook, By Research Institutions (2024-2032) ($MN)
  • Table 102 Asia Pacific AI Chronic Pain Management Market Outlook, By Academic Centers (2024-2032) ($MN)
  • Table 103 Asia Pacific AI Chronic Pain Management Market Outlook, By Nursing Homes (2024-2032) ($MN)
  • Table 104 Asia Pacific AI Chronic Pain Management Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 105 South America AI Chronic Pain Management Market Outlook, By Country (2024-2032) ($MN)
  • Table 106 South America AI Chronic Pain Management Market Outlook, By Component (2024-2032) ($MN)
  • Table 107 South America AI Chronic Pain Management Market Outlook, By Software (2024-2032) ($MN)
  • Table 108 South America AI Chronic Pain Management Market Outlook, By Hardware (2024-2032) ($MN)
  • Table 109 South America AI Chronic Pain Management Market Outlook, By Services (2024-2032) ($MN)
  • Table 110 South America AI Chronic Pain Management Market Outlook, By Deployment Mode (2024-2032) ($MN)
  • Table 111 South America AI Chronic Pain Management Market Outlook, By Cloud-Based (2024-2032) ($MN)
  • Table 112 South America AI Chronic Pain Management Market Outlook, By On-Premises (2024-2032) ($MN)
  • Table 113 South America AI Chronic Pain Management Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 114 South America AI Chronic Pain Management Market Outlook, By Online Platforms (2024-2032) ($MN)
  • Table 115 South America AI Chronic Pain Management Market Outlook, By Offline (2024-2032) ($MN)
  • Table 116 South America AI Chronic Pain Management Market Outlook, By Application (2024-2032) ($MN)
  • Table 117 South America AI Chronic Pain Management Market Outlook, By Neuropathic Pain (2024-2032) ($MN)
  • Table 118 South America AI Chronic Pain Management Market Outlook, By Musculoskeletal Pain (2024-2032) ($MN)
  • Table 119 South America AI Chronic Pain Management Market Outlook, By Cancer-related Pain (2024-2032) ($MN)
  • Table 120 South America AI Chronic Pain Management Market Outlook, By Migraine and Facial Pain (2024-2032) ($MN)
  • Table 121 South America AI Chronic Pain Management Market Outlook, By Fibromyalgia (2024-2032) ($MN)
  • Table 122 South America AI Chronic Pain Management Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 123 South America AI Chronic Pain Management Market Outlook, By End User (2024-2032) ($MN)
  • Table 124 South America AI Chronic Pain Management Market Outlook, By Hospitals and Clinics (2024-2032) ($MN)
  • Table 125 South America AI Chronic Pain Management Market Outlook, By Homecare (2024-2032) ($MN)
  • Table 126 South America AI Chronic Pain Management Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 127 South America AI Chronic Pain Management Market Outlook, By Research Institutions (2024-2032) ($MN)
  • Table 128 South America AI Chronic Pain Management Market Outlook, By Academic Centers (2024-2032) ($MN)
  • Table 129 South America AI Chronic Pain Management Market Outlook, By Nursing Homes (2024-2032) ($MN)
  • Table 130 South America AI Chronic Pain Management Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 131 Middle East & Africa AI Chronic Pain Management Market Outlook, By Country (2024-2032) ($MN)
  • Table 132 Middle East & Africa AI Chronic Pain Management Market Outlook, By Component (2024-2032) ($MN)
  • Table 133 Middle East & Africa AI Chronic Pain Management Market Outlook, By Software (2024-2032) ($MN)
  • Table 134 Middle East & Africa AI Chronic Pain Management Market Outlook, By Hardware (2024-2032) ($MN)
  • Table 135 Middle East & Africa AI Chronic Pain Management Market Outlook, By Services (2024-2032) ($MN)
  • Table 136 Middle East & Africa AI Chronic Pain Management Market Outlook, By Deployment Mode (2024-2032) ($MN)
  • Table 137 Middle East & Africa AI Chronic Pain Management Market Outlook, By Cloud-Based (2024-2032) ($MN)
  • Table 138 Middle East & Africa AI Chronic Pain Management Market Outlook, By On-Premises (2024-2032) ($MN)
  • Table 139 Middle East & Africa AI Chronic Pain Management Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 140 Middle East & Africa AI Chronic Pain Management Market Outlook, By Online Platforms (2024-2032) ($MN)
  • Table 141 Middle East & Africa AI Chronic Pain Management Market Outlook, By Offline (2024-2032) ($MN)
  • Table 142 Middle East & Africa AI Chronic Pain Management Market Outlook, By Application (2024-2032) ($MN)
  • Table 143 Middle East & Africa AI Chronic Pain Management Market Outlook, By Neuropathic Pain (2024-2032) ($MN)
  • Table 144 Middle East & Africa AI Chronic Pain Management Market Outlook, By Musculoskeletal Pain (2024-2032) ($MN)
  • Table 145 Middle East & Africa AI Chronic Pain Management Market Outlook, By Cancer-related Pain (2024-2032) ($MN)
  • Table 146 Middle East & Africa AI Chronic Pain Management Market Outlook, By Migraine and Facial Pain (2024-2032) ($MN)
  • Table 147 Middle East & Africa AI Chronic Pain Management Market Outlook, By Fibromyalgia (2024-2032) ($MN)
  • Table 148 Middle East & Africa AI Chronic Pain Management Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 149 Middle East & Africa AI Chronic Pain Management Market Outlook, By End User (2024-2032) ($MN)
  • Table 150 Middle East & Africa AI Chronic Pain Management Market Outlook, By Hospitals and Clinics (2024-2032) ($MN)
  • Table 151 Middle East & Africa AI Chronic Pain Management Market Outlook, By Homecare (2024-2032) ($MN)
  • Table 152 Middle East & Africa AI Chronic Pain Management Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 153 Middle East & Africa AI Chronic Pain Management Market Outlook, By Research Institutions (2024-2032) ($MN)
  • Table 154 Middle East & Africa AI Chronic Pain Management Market Outlook, By Academic Centers (2024-2032) ($MN)
  • Table 155 Middle East & Africa AI Chronic Pain Management Market Outlook, By Nursing Homes (2024-2032) ($MN)
  • Table 156 Middle East & Africa AI Chronic Pain Management Market Outlook, By Other End Users (2024-2032) ($MN)